463 related items for PubMed ID: 19438983
1. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease.
Kuo HC, Wang CL, Liang CD, Yu HR, Huang CF, Wang L, Hwang KP, Yang KD.
Pediatr Allergy Immunol; 2009 May; 20(3):266-72. PubMed ID: 19438983
[Abstract] [Full Text] [Related]
2. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
[Abstract] [Full Text] [Related]
3. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma.
Chu YT, Chiang W, Wang TN, Hung CH, Jong YJ, Wu JR.
J Microbiol Immunol Infect; 2007 Apr; 40(2):162-7. PubMed ID: 17446966
[Abstract] [Full Text] [Related]
4. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
Kuo HC, Wang CL, Liang CD, Yu HR, Chen HH, Wang L, Yang KD.
J Microbiol Immunol Infect; 2007 Oct; 40(5):395-400. PubMed ID: 17932598
[Abstract] [Full Text] [Related]
5. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease.
Kuo HC, Yang KD, Liang CD, Bong CN, Yu HR, Wang L, Wang CL.
Pediatr Allergy Immunol; 2007 Jun; 18(4):354-9. PubMed ID: 17584314
[Abstract] [Full Text] [Related]
6. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X, Li CR, Yang J, Wang GB.
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[Abstract] [Full Text] [Related]
7. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis.
Bullock JZ, Villanueva JM, Blanchard C, Filipovich AH, Putnam PE, Collins MH, Risma KA, Akers RM, Kirby CL, Buckmeier BK, Assa'ad AH, Hogan SP, Rothenberg ME.
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):22-31. PubMed ID: 17592361
[Abstract] [Full Text] [Related]
8. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q, Wu Q, Chen CH, Hong H, Zhang LY.
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[Abstract] [Full Text] [Related]
9. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
Simonini G, Masi L, Giani T, Piscitelli E, Cimaz R, Vierucci S, Brandi ML, Falcini F.
J Rheumatol; 2005 Nov; 32(11):2233-8. PubMed ID: 16265708
[Abstract] [Full Text] [Related]
10. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.
Guo MM, Tseng WN, Ko CH, Pan HM, Hsieh KS, Kuo HC.
Allergy; 2015 Mar; 70(3):310-8. PubMed ID: 25585854
[Abstract] [Full Text] [Related]
11. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J, Jiang F, Nayeri F, Zetterström O.
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[Abstract] [Full Text] [Related]
12. Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.
Masuzawa Y, Mori M, Hara T, Inaba A, Oba MS, Yokota S.
Ther Apher Dial; 2015 Apr; 19(2):171-7. PubMed ID: 25257673
[Abstract] [Full Text] [Related]
13. Plasma eosinophil cationic protein, interleukin-5, and ECP/Eo count ratio in patients with various eosinophilic diseases.
Park YJ, Oh EJ, Park JW, Kim M, Han K.
Ann Clin Lab Sci; 2006 Apr; 36(3):262-6. PubMed ID: 16951266
[Abstract] [Full Text] [Related]
14. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
Iino Y, Kakizaki K, Katano H, Saigusa H, Kanegasaki S.
Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
[Abstract] [Full Text] [Related]
15. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease.
Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, Kuroe K, Shimpo H, Nakano M, Komada Y.
Circulation; 2005 Jan 04; 111(1):38-43. PubMed ID: 15611368
[Abstract] [Full Text] [Related]
16. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
Khowsathit P, Hong-Hgam C, Khositseth A, Wanitkun S.
J Med Assoc Thai; 2002 Nov 04; 85 Suppl 4():S1121-6. PubMed ID: 12549785
[Abstract] [Full Text] [Related]
17. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.
Kuo HC, Yang YL, Chuang JH, Tiao MM, Yu HR, Huang LT, Yang KD, Chang WC, Lee CP, Huang YH.
J Clin Immunol; 2012 Aug 04; 32(4):746-52. PubMed ID: 22392047
[Abstract] [Full Text] [Related]
18. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
Abe J, Ebata R, Jibiki T, Yasukawa K, Saito H, Terai M.
J Allergy Clin Immunol; 2008 Nov 04; 122(5):1008-1013.e8. PubMed ID: 18930517
[Abstract] [Full Text] [Related]
19. Activity and turnover of eosinophil and neutrophil granulocytes are altered in visceral leishmaniasis.
Elshafie AI, Hlin E, Håkansson LD, Elghazali G, Safi SH, Rönnelid J, Venge P.
Int J Parasitol; 2011 Mar 04; 41(3-4):463-9. PubMed ID: 21172349
[Abstract] [Full Text] [Related]
20. Expression of Fc<gamma>Rs on monocytes among Kawasaki disease patients with coronary artery lesions.
Xia Y, Tian X, Li Q, Wang G, Li C, Yang J.
Int Immunopharmacol; 2017 Apr 04; 45():1-5. PubMed ID: 28147297
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
